InvestorsHub Logo
Followers 3
Posts 383
Boards Moderated 0
Alias Born 08/25/2012

Re: Richard2 post# 14732

Saturday, 01/16/2016 2:22:39 PM

Saturday, January 16, 2016 2:22:39 PM

Post# of 15662
Yes, I agree, huge income potential. Biotech's are event driven. We'll have some events in 2016.

Well, it's complex at every turn, historically, politically and scientifically. In my view, one reason is, the company has been stigmatized similarly to how ME/CFS patients have been stigmatized (in the past, things have changed in 2015). There is no reason that heb should not have gotten fast track status. The problem with doing so is that the FDA would have to admit that CFS is a real disease. So, things are changing - in the 30+ years of ME/CFS disease - last October was the first time an NIH director had ever mentioned CFS/ME... and for that matter using ampligen in a ME/CFS trial.

So, there is a history of stigma, both patients and company and there are a couple of small predatory hedge funds who have taken advantage of this stigma to make money. Manuel Asensio, Adam Feuerstein, theStreet etc. They would like either or both, to see the company fail, or, if not, to pick up cheap shares from scared investors. You can find them on the yahoo heb board where they can create multiple IDs and post lies with apparent impunity. Some of those ids have been posting for 18 years - they've made lots of money manipulating the stock. If you want to see Jim Cramer boasting about manipulating stocks, google: "jim cramer manipulating video" - he didn't think it would be broadcast.

If you've seen "The Big Short" think of heb as "The Big Long" - we're going to make money because we don't believe the manipulating hedge funds, 'we looked' for ourselves.

Happy New Year